Maintenance fees coming due
7 maintenance fees come due in the 12 months from Nov 18, 2026, the next on Feb 8, 2027. Unpaid by Aug 9, 2027, that one lapses early.
A maintenance fee does not end a patent on its due date. It falls due at 3.5, 7.5
and 11.5 years from grant, and the patent lapses only if the fee is still unpaid at the end of the
six month grace period that follows.
| Patent | Title | Holder | Status | Fee due | Lapses if unpaid | Expires | Confidence |
|---|---|---|---|---|---|---|---|
| US 11,718,588 | 5-[(PIPERAZIN-1-YL)-3-OXO-PROPYL]-IMIDAZOLIDINE-2,4-Dione Derivatives as Adamts Inhibitors for the Treatment of Osteoarthritis In force Fee due Feb 8, 2027 Lapses if unpaid Aug 9, 2027 · Medium confidence | Lakefront Biotherapeutics | In force | Feb 8, 2027 | Aug 9, 2027 | Medium confidence | |
| US 10,487,060 | 5-[(PIPERAZIN-1-YL)-3-OXO-PROPYL]-IMIDAZOLIDINE-2,4-Dione Derivatives as Adamts Inhibitors for the Treatment of Osteoarthritis In force Fee due May 26, 2027 Lapses if unpaid Nov 26, 2027 · Low confidence | Lakefront Biotherapeutics | In force | May 26, 2027 | Nov 26, 2027 | Low confidence | |
| US 10,526,329 | Novel Compounds and Pharmaceutical Compositions Thereof for the Treatment of Inflammatory Disorders In force Fee due Jul 7, 2027 Lapses if unpaid Jan 7, 2028 · High confidence | Lakefront Biotherapeutics | In force | Jul 7, 2027 | Jan 7, 2028 | High confidence | |
| US 9,241,931 | Novel Compound Useful for the Treatment of Degenerative and Inflammatory Diseases In force Fee due Jul 26, 2027 Lapses if unpaid Jan 26, 2028 · High confidence | Lakefront Biotherapeutics | In force | Jul 26, 2027 | Jan 26, 2028 | High confidence | |
| US 9,249,141 | Novel Compounds and Pharmaceutical Compositions Thereof for the Treatment of Inflammatory Disorders In force Fee due Aug 2, 2027 Lapses if unpaid Feb 2, 2028 · High confidence | Lakefront Biotherapeutics | In force | Aug 2, 2027 | Feb 2, 2028 | High confidence | |
| US 9,255,095 | Novel Dihydropyrimidinoisoquinolinones and Pharmaceutical Compositions Thereof for the Treatment of Inflammatory Disorders. In force Fee due Aug 9, 2027 Lapses if unpaid Feb 9, 2028 · High confidence | Lakefront Biotherapeutics | In force | Aug 9, 2027 | Feb 9, 2028 | High confidence | |
| US 10,568,879 | Novel Dihydropyridoisoquinolinones and Pharmaceutical Compositions Thereof for the Treatment of Inflammatory Disorders In force Fee due Aug 25, 2027 Lapses if unpaid Feb 25, 2028 · High confidence | Lakefront Biotherapeutics | In force | Aug 25, 2027 | Feb 25, 2028 | High confidence |
7 of 7 patents shown. Soonest fee due date first, then patent number.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.